Quarterly report · Q3
4361.TEDINET S100PAIT
Period2021-12-01 → 2022-08-31
Filed2022-10-11
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥6.1bn | 2021-12-01 → 2022-08-31 | Cons. | Net sales |
| Revenue | ¥7.9bn | 2020-12-01 → 2021-11-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥5.8bn | 2020-12-01 → 2021-08-31 | Cons. | Net sales |
| Operating income | ¥331m | 2021-12-01 → 2022-08-31 | Cons. | Operating income |
| Operating income | ¥347m | 2020-12-01 → 2021-08-31 | Cons. | Operating income |
| Ordinary income | ¥345m | 2021-12-01 → 2022-08-31 | Cons. | Ordinary income |
| Ordinary income | ¥386m | 2020-12-01 → 2021-11-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥349m | 2020-12-01 → 2021-08-31 | Cons. | Ordinary income |
| Profit before tax | ¥343m | 2021-12-01 → 2022-08-31 | Cons. | Income before income taxes |
| Profit before tax | ¥357m | 2020-12-01 → 2021-08-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥266m | 2021-12-01 → 2022-08-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥281m | 2020-12-01 → 2021-11-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥259m | 2020-12-01 → 2021-08-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥266m | 2021-12-01 → 2022-08-31 | Cons. | Profit loss |
| Net income | ¥259m | 2020-12-01 → 2021-08-31 | Cons. | Profit loss |
| Total assets | ¥8.3bn | at 2022-08-31 | Cons. | Assets |
| Total assets | ¥7.9bn | at 2021-11-30 | Cons. | Assets |
| Total assets | ¥7.7bn | at 2021-08-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥5.9bn | at 2022-08-31 | Cons. | Liabilities |
| Total liabilities | ¥5.6bn | at 2021-11-30 | Cons. | Liabilities |
| Net assets / equity | ¥2.5bn | at 2022-08-31 | Cons. | Net assets |
| Net assets / equity | ¥2.3bn | at 2021-11-30 | Cons. | Net assets |
| Net assets / equity | ¥2.2bn | at 2021-08-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥1.1bn | at 2022-08-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥1.3bn | at 2021-11-30 | Cons. | Cash and deposits |
| EPS (basic) | ¥218.07 | 2021-12-01 → 2022-08-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥71.01 | 2022-06-01 → 2022-08-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥230.99 | 2020-12-01 → 2021-11-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥213.08 | 2020-12-01 → 2021-08-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥52.78 | 2021-06-01 → 2021-08-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 29.6% | at 2022-08-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 28.5% | at 2021-11-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 28.8% | at 2021-08-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 18
| Segment | Item | Period | Value |
|---|---|---|---|
| jpcrp040300-q3r_E01006-000Pharmaceutical Productsreportable segment | revenue | 2021-12-01 → 2022-08-31 | ¥6.1bn |
| jpcrp040300-q3r_E01006-000Pharmaceutical Productsreportable segment | revenue external | 2021-12-01 → 2022-08-31 | ¥6.1bn |
| jpcrp040300-q3r_E01006-000Pharmaceutical Productsreportable segment | segment profit | 2021-12-01 → 2022-08-31 | ¥308m |
| jpcrp040300-q3r_E01006-000Real Estate Leasingreportable segment | revenue | 2021-12-01 → 2022-08-31 | ¥29m |
| jpcrp040300-q3r_E01006-000Real Estate Leasingreportable segment | revenue external | 2021-12-01 → 2022-08-31 | ¥29m |
| jpcrp040300-q3r_E01006-000Real Estate Leasingreportable segment | segment profit | 2021-12-01 → 2022-08-31 | ¥23m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-12-01 → 2022-08-31 | ¥6.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-12-01 → 2022-08-31 | ¥6.1bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-12-01 → 2022-08-31 | ¥331m |
| jpcrp040300-q3r_E01006-000Pharmaceutical Productsreportable segment | revenue | 2020-12-01 → 2021-08-31 | ¥5.7bn |
| jpcrp040300-q3r_E01006-000Pharmaceutical Productsreportable segment | revenue external | 2020-12-01 → 2021-08-31 | ¥5.7bn |
| jpcrp040300-q3r_E01006-000Pharmaceutical Productsreportable segment | segment profit | 2020-12-01 → 2021-08-31 | ¥324m |
| jpcrp040300-q3r_E01006-000Real Estate Leasingreportable segment | revenue | 2020-12-01 → 2021-08-31 | ¥28m |
| jpcrp040300-q3r_E01006-000Real Estate Leasingreportable segment | revenue external | 2020-12-01 → 2021-08-31 | ¥28m |
| jpcrp040300-q3r_E01006-000Real Estate Leasingreportable segment | segment profit | 2020-12-01 → 2021-08-31 | ¥23m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2020-12-01 → 2021-08-31 | ¥5.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2020-12-01 → 2021-08-31 | ¥5.8bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2020-12-01 → 2021-08-31 | ¥347m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 352
| Item | Context | Value | Unit |
|---|---|---|---|
| Income taxes payable | Prior1YearInstant | 89811000 | JPY |
| Income taxes payable | CurrentQuarterInstant | 35845000 | JPY |
| Accrued consumption taxes | Prior1YearInstant | 38468000 | JPY |
| Accrued consumption taxes | CurrentQuarterInstant | - | JPY |
| Provision for bonuses | Prior1YearInstant | - | JPY |
| Provision for bonuses | CurrentQuarterInstant | 81426000 | JPY |
| Provision for directors bonuses | Prior1YearInstant | 19800000 | JPY |
| Provision for directors bonuses | CurrentQuarterInstant | 11250000 | JPY |
| Other cl | Prior1YearInstant | 288351000 | JPY |
| Other cl | CurrentQuarterInstant | 72692000 | JPY |
| Current liabilities | Prior1YearInstant | 4535032000 | JPY |
| Current liabilities | CurrentQuarterInstant | 4377840000 | JPY |
| Long term loans payable | Prior1YearInstant | 580019000 | JPY |
| Long term loans payable | CurrentQuarterInstant | 991152000 | JPY |
| Provision for directors retirement benefits | Prior1YearInstant | 125990000 | JPY |
| Provision for directors retirement benefits | CurrentQuarterInstant | 99765000 | JPY |
| Net defined benefit liability | Prior1YearInstant | 274739000 | JPY |
| Net defined benefit liability | CurrentQuarterInstant | 278824000 | JPY |
| Other ncl | Prior1YearInstant | 125924000 | JPY |
| Other ncl | CurrentQuarterInstant | 131909000 | JPY |
| Noncurrent liabilities | Prior1YearInstant | 1106672000 | JPY |
| Noncurrent liabilities | CurrentQuarterInstant | 1501650000 | JPY |
| Liabilities | Prior1YearInstant | 5641705000 | JPY |
| Liabilities | CurrentQuarterInstant | 5879491000 | JPY |
| Capital stock | Prior1YearInstant | 610000000 | JPY |
| Capital stock | CurrentQuarterInstant | 610000000 | JPY |
| Capital surplus | Prior1YearInstant | 58437000 | JPY |
| Capital surplus | CurrentQuarterInstant | 58437000 | JPY |
| Retained earnings | Prior1YearInstant | 1528465000 | JPY |
| Retained earnings | CurrentQuarterInstant | 1733101000 | JPY |
| Treasury stock | Prior1YearInstant | -8067000 | JPY |
| Treasury stock | CurrentQuarterInstant | -8067000 | JPY |
| Shareholders equity | Prior1YearInstant | 2188836000 | JPY |
| Shareholders equity | CurrentQuarterInstant | 2393472000 | JPY |
| Valuation difference on available for sale securities | Prior1YearInstant | 42413000 | JPY |
| Valuation difference on available for sale securities | CurrentQuarterInstant | 29245000 | JPY |
| Foreign currency translation adjustment | Prior1YearInstant | 21325000 | JPY |
| Foreign currency translation adjustment | CurrentQuarterInstant | 43672000 | JPY |
| Valuation and translation adjustments | Prior1YearInstant | 63739000 | JPY |
| Valuation and translation adjustments | CurrentQuarterInstant | 72917000 | JPY |
| Net assets | Prior1YearInstant | 2252575000 | JPY |
| Net assets | CurrentQuarterInstant | 2466389000 | JPY |
| Liabilities and net assets | Prior1YearInstant | 7894280000 | JPY |
| Liabilities and net assets | CurrentQuarterInstant | 8345881000 | JPY |
| Net sales | Prior1YTDDuration | 5763742000 | JPY |
| Net sales | CurrentYTDDuration | 6086144000 | JPY |
| Cost of sales | Prior1YTDDuration | 4556043000 | JPY |
| Cost of sales | CurrentYTDDuration | 4879258000 | JPY |
| Gross profit | Prior1YTDDuration | 1207699000 | JPY |
| Gross profit | CurrentYTDDuration | 1206886000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |